|
UBE2H expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.583000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.175600E-01 |
| Normal-vs-Stage2 |
4.846000E-01 |
| Normal-vs-Stage3 |
1.419410E-01 |
| Normal-vs-Stage4 |
1.309610E-01 |
| Stage1-vs-Stage2 |
9.730400E-01 |
| Stage1-vs-Stage3 |
3.162800E-01 |
| Stage1-vs-Stage4 |
3.536000E-01 |
| Stage2-vs-Stage3 |
5.118600E-01 |
| Stage2-vs-Stage4 |
4.570000E-01 |
| Stage3-vs-Stage4 |
8.848800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.245800E-01 |
| Normal-vs-AfricanAmerican |
6.228000E-01 |
| Normal-vs-Asian |
2.731600E-01 |
| Caucasian-vs-AfricanAmerican |
2.202800E-01 |
| Caucasian-vs-Asian |
7.052800E-01 |
| AfricanAmerican-vs-Asian |
2.013400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.528300E-02 |
| Normal-vs-Female |
4.250000E-01 |
| Male-vs-Female |
1.184360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.648800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.576800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.702200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.366380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.771800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.107500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.395000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.646030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.540800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.461000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.406040E-01 |
| Classical-VS-Follicular |
3.831600E-04 |
| Classical-VS-Other |
1.914560E-01 |
| Classical-VS-Normal |
9.329000E-01 |
| Tall-VS-Follicular |
4.166000E-01 |
| Tall-VS-Other |
5.357800E-01 |
| Tall-VS-Normal |
1.500370E-01 |
| Follicular-VS-Other |
8.916000E-01 |
| Follicular-VS-Normal |
8.082900E-03 |
| Other-VS-Normal |
1.687790E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.457600E-02 |
| Normal-vs-N1 |
1.964770E-01 |
| N0-vs-N1 |
9.562800E-01 |
|
|
